Physician profile
Patrick Ho
NPI 1578094223
$11,104.55
in general payments reported to CMS, 2019-2025
32 companies · $8,004 in 2025
The $8,004 reported for 2025 was more than what 91% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.30 · 2020: $32.30 · 2022: $241 · 2023: $1,021 · 2024: $1,790 · 2025: $8,004.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,631 · Education: $4,006 · Travel and Lodging: $677 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,631.48 |
| Education | $4,006.23 |
| Travel and Lodging | $677.15 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,477.69 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $1,341.98 | 2022-2025 | Fasenra, Breztri, Tezspire |
| Glaxosmithkline, LLC. | $897.40 | 2020-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $788.21 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $565.98 | 2022-2025 | Dupixent |
| Verona Pharma, INC. | $213.45 | 2025 | Ohtuvayre |
| Philips North America LLC | $200.11 | 2023-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Takeda Pharmaceuticals U.S.A., INC. | $162.69 | 2022-2025 | Aralast |
| Boehringer Ingelheim Pharmaceuticals, INC. | $156.55 | 2022-2025 | Ofev, Jascayd |
| Insmed, INC. | $153.75 | 2024-2025 | Arikayce, Brinsupri |
| Amgen INC. | $152.57 | 2022-2025 | Tezspire |
| Baxter Healthcare | $106.36 | 2023-2025 | Hillrom - Life 2000 Ventilation System |
| Genentech USA, INC. | $102.45 | 2023-2025 | Xolair |
| Lilly USA, LLC | $98.31 | 2025 | Zepbound |
| Mylan Specialty L.P. | $92.03 | 2024 | Yupelri |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $86.80 | 2023-2025 | Smartvest |
| Grifols USA, LLC | $68.29 | 2024-2025 | Prolastin-C Liquid |
| Jazz Pharmaceuticals INC. | $49.12 | 2023-2024 | |
| Inspire Medical Systems, INC. | $44.44 | 2024 | Inspire |
| Actelion Pharmaceuticals US, INC. | $43.91 | 2022-2025 | Opsumit, Uptravi |
| United Therapeutics Corporation | $43.48 | 2022-2025 | Tyvaso |
| Pfizer INC. | $38.75 | 2024 | |
| Mallinckrodt Hospital Products INC. | $35.14 | 2023 | Acthar |
| Viatris Specialty LLC | $33.22 | 2025 | Yupelri |
| Irhythm Technologies, INC. | $28.12 | 2024 | Zio Xt Patch, Zio Monitor |
| Inogen, INC. | $21.35 | 2023 | Inogen One G3 Oxygen Concentrator |
| Harmony Biosciences LLC | $18.22 | 2025 | |
| Gilead Sciences, INC. | $18.16 | 2025 | Veklury |
| Boston Scientific Corporation | $16.78 | 2023 | Rezum Generator |
| Axsome Therapeutics, INC. | $16.63 | 2023 | Sunosi |
| Avadel Cns Pharmaceuticals, LLC | $16.31 | 2023 | Lumryz |
| Amneal Pharmaceuticals LLC | $16.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.